Endogenex is a clinical stage company, that in partnership with Mayo Clinic, was founded to improve outcomes for people living with Type 2 Diabetes. Endogenex’s focus is on the principle that effective treatment for Type 2 Diabetes can extend beyond pharmacologic options and reset the disease process. Through development of the endoscopic ReCET^TM Procedure and the novel application of non-thermal pulsed electric fields, Endogenex is striving to help people with Type 2 Diabetes regain control of their blood glucose levels.